Introgen Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer and other diseases. Introgen is developing molecular therapeutics, immunotherapies, vaccines and nano-particle tumor suppressor therapies to treat a wide range of cancers using tumor suppressors, cytokines and genes. Introgen maintains integrated research, development, manufacturing, clinical and regulatory departments and operates multiple manufacturing facilities including a commercial scale cGMP manufacturing facility.
View Top Employees from Introgen Therapeutics, Inc.| Website | http://www.introgen.com |
| Revenue | $23 million |
| Employees | 11 (5 on RocketReach) |
| Address | 301 Congress Ave, Ste 1850, Austin, Texas 78701, US |
| Phone | (512) 708-9310 |
| Fax | (512) 708-9311 |
| Industry | Biotechnology Research, Biotechnology, Pharmaceuticals, Healthcare |
| Competitors | AGTC, Adverum Biotechnologies, Denali Therapeutics, MeiraGTx, Oxford Biomedica |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541713 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies |
Looking for a particular Introgen Therapeutics, Inc. employee's phone or email?
Introgen Therapeutics, Inc. Questions
The Introgen Therapeutics, Inc. annual revenue was $23 million in 2023.
Don Martin is the Director, CMC QA of Introgen Therapeutics, Inc..
5 people are employed at Introgen Therapeutics, Inc..
Introgen Therapeutics, Inc. is based in Austin, Texas.
The NAICS codes for Introgen Therapeutics, Inc. are [541713, 5417, 541, 54, 54171].
The SIC codes for Introgen Therapeutics, Inc. are [87, 873].
Top Introgen Therapeutics, Inc. Employees
-
55+
-
23
-
21
Related Companies
